Role of p16INK4a in the inhibition of DNA synthesis stimulated by HGF or EGF in primary cultured rat hepatocytes

Biomedical Research (Japan)

Volumn 34, Issue 5, 2013, Pages 269-273

  Harashima, Mizuho ^a   Seki, Taiichiro ^a   Ariga, Toyohiko ^a   Niimi, Shingo ^b  

^a NIHON UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; EPIDERMAL GROWTH FACTOR; MESSENGER RNA; SCATTER FACTOR; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; GENE EXPRESSION; LIVER CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; RNA INTERFERENCE;

ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA REPLICATION; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; RATS; RNA INTERFERENCE; RNA, MESSENGER;

EID: 84887053303     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.34.269     Document Type: Article

References (21)

1. Auer KL, Park JS, Seth P, Coffey RJ, Darlington G, Abo A, McMahon M, Depinho RA, Fisher PB and Dent P (1998) Prolonged activation of the mitogen-activated protein kinase pathway promotes DNA synthesis in primary hepatocytes from p21Cip-1/WAF1-null mice, but not in hepatocytes from p16INK4a-null mice. Biochem J 336 (Pt 3), 551-560.
2. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72, 248-254.
3. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
4. Gerard C and Goldbeter A (2009) Temporal self-organization of the cyclin/Cdk network driving the mammalian cell cycle. Proc Natl Acad Sci USA 106, 21643-21648.
5. Harper JW and Elledge SJ (1996) Cdk inhibitors in development and cancer. Curr Opin Genet Dev 6, 56-64.
6. Ilyin GP, Glaise D, Gilot D, Baffet G and Guguen-Guillouzo C (2003) Regulation and role of p21 and p27 cyclin-dependent kinase inhibitors during hepatocyte differentiation and growth. Am J Physiol Gastrointest Liver Physiol 285, G115-1127.
7. 2+/PKC and MAPKs. J Cell Biochem 99, 1677-1687.
8. Matsuda Y, Ichida T, Matsuzawa J, Sugimura K and Asakura H (1999) p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma. Gastroenterology 116, 394-400.
9. Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW and Elledge SJ (1995) p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9, 650-662.
10. Niimi S, Horikawa M, Seki T, Ariga T, Kobayashi T and Hayakawa T (2002) Effect of activins AB and B on DNA synthesis stimulated by epidermal growth factor in primary cultured rat hepatocytes. Biol Pharm Bull 25, 437-440.
11. Noda A, Ning Y, Venable SF, Pereira-Smith OM and Smith JR (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211, 90-98.
12. Pascale RM, Simile MM, Calvisi DF, Frau M, Muroni MR, Seddaiu MA, Daino L, Muntoni MD, De Miglio MR, Thorgeirsson SS and Feo F (2005) Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer. Hepatology 42, 1310-1319.
13. Pascale RM, Simile MM, De Miglio MR, Muroni MR, Calvisi DF, Asara G, Casabona D, Frau M, Seddaiu MA and Feo F (2002) Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis. Hepatology 35, 1341-1350.
14. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P and Massague J (1994) Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.
15. Sherr CJ and Roberts JM (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9, 1149-1163.
16. Sherr CJ and Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13, 1501-1512.
17. Shim YH, Park HJ, Choi MS, Kim JS, Kim H, Kim JJ, Jang JJ and Yu E (2003) Hypermethylation of the p16 gene and lack of p16 expression in hepatoblastoma. Mod Pathol 16, 430-436.
18. Tanaka K, Sato M, Tomita Y and Ichihara A (1978) Biochemical studies on liver functions in primary cultured hepatocytes of adult rats. I. Hormonal effects on cell viability and protein synthesis J Biochem 84, 937-946.
19. Toyoshima H and Hunter T (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74.
20. Ueberham E, Lindner R, Kamprad M, Hiemann R, Hilger N, Woithe B, Mahn D, Cross M, Sack U, Gebhardt R, Arendt T and Ueberham U (2008) Oval cell proliferation in p16INK4a expressing mouse liver is triggered by chronic growth stimuli. J Cell Mol Med 12, 622-638.
21. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-714.